Published in Medical Letter on the CDC and FDA, April 1st, 1996
Mycobacterium tuberculosis induces several immune alterations in humans. Blood monocytes from tuberculosis patients show signs of activation, whereas T-cell responses to mycobacterial antigens in vitro are sometimes very low.
"The latter phenomenon may be explained by active blood monocyte-mediated suppression and by intrinsic T-cell anergy," researcher G. Vanham and colleagues wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.